MC

Megan Canniere

EVP, Chief Development Officer

Spark Therapeutics, Inc.

Philadelphia, Pennsylvania


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Spark Therapeutics, Inc.
Industry
research
Employees
820.0
Seniority
C suite
Annual Revenue
93500000.0

Professional Summary

Megan Canniere serves as EVP, Chief Development Officer at Spark Therapeutics, Inc.. Spark Therapeutics, Inc. operates in the research sector with approximately 820.0 employees. The company is headquartered in Philadelphia, Pennsylvania. Spark Therapeutics, Inc. generates annual revenue of 93500000.0.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • 2,637 executive contacts are available in Pennsylvania.
  • Our database includes 201,469 c suite-level executives.

Technologies

Route 53 Mimecast Amazon AWS Drupal WP Engine Salesforce Sophos SuccessFactors (SAP) Multilingual Act-On Mobile Friendly Typekit WordPress.org Google Tag Manager Vimeo Bootstrap Framework Google Font API Google Analytics Linkedin Marketing Solutions reCAPTCHA Remote

Keywords

biotechnology & gene therapy biotechnology: biological products (no diagnostic substances) health care biotechnology research gene therapy aav vectors inherited diseases retinal diseases hemophilia treatment neurodegenerative diseases r&d manufacturing commercial operations regulatory strategies patient care clinical trials therapeutic modalities genetic treatments genomic research personalized medicine investigational therapies life-altering transformations healthcare transformation corporate social responsibility community engagement patient safety ethical practices sustainability environmental impact cross-functional collaboration innovation center biotech manufacturing healthcare professionals genetic conditions drug discovery patient advocacy scientific community genetic disease treatments long-term effects clinical development supply chain management quality assurance patient support programs medicinal innovation compassionate use healthcare equity healthcare accessibility patient-centric approach clinical endpoints genetic diseases rare diseases inherited retinal disorders hemophilia lysosomal storage disorders luxturna fidanacogene elaparvovec spk-8011 spk-7001 spk-3006 spk-1001 adeno-associated viral vector one-time treatments patient-centric innovative therapies pharmaceutical industry partnerships research & development healthcare providers insurance coverage patient outcomes genetic disorder treatment gene therapy innovation center strategic collaborations market access breakthrough therapy designation healthcare innovation health wellness & fitness mechanical or industrial engineering hospital & health care environmental services renewables & environment logistics & supply chain

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Megan Canniere in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Spark Therapeutics, Inc..

Megan Canniere's Position in the MessageCEO Database

  • Megan Canniere is 1 of 1 verified executive contact we track at Spark Therapeutics, Inc..
  • 2,871 verified executive contacts in research are in the MessageCEO database.
  • 2,484 verified executive contacts in Pennsylvania are in the database.
  • 11 verified contacts work at research companies in the 820.0 employee range (same size as Spark Therapeutics, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

Frequently Asked Questions

How do I reach Megan Canniere directly?

Megan Canniere's verified email address is available to MessageCEO Pro subscribers. They currently serve as EVP, Chief Development Officer at Spark Therapeutics, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Megan Canniere work for?

Megan Canniere is EVP, Chief Development Officer at Spark Therapeutics, Inc., a company in the research sector with 820.0 employees. The company is based in Philadelphia, Pennsylvania.

Can I pitch or sell to Megan Canniere?

As EVP, Chief Development Officer at Spark Therapeutics, Inc., Megan Canniere is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Megan Canniere directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Megan Canniere in?

Megan Canniere works in the research industry as EVP, Chief Development Officer at Spark Therapeutics, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Megan Canniere's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Megan Canniere's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: June 25, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans